Assessment of Antidiabetic Potential of Polyherbal Formulations
Introduction: Diabetes provides a major challenge to the present population globally. It is a major threat to global public health that is rapidly reaching epidemic scale. Plant based drugs are gaining importance to treat majority of human aliments including diabetes mellitus due to their less toxic effects. Aims: The present study was designed to assess the antidiabetic potential of polyherbal formulations in streptozotocin induced diabetic rats. Methods: Diabetes was induced by single intraperitoneal injection of streptozotocin (50 mg/kg) in male Wistar rats. Rats with fasting blood glucose levels ≥ 250 mg/dl after seven days of STZ administration were randomized into different groups and were treated with Formulation-1 (F1) and Formulation-2 (F2) in graded doses for 21 days. At the end of the study, blood glucose, lipid profiles were estimated. In addition, enzymatic and non-enzymatic liver antioxidant levels were also estimated. To elucidate the mode of action, we evaluated its effects on oral glucose tolerance test in normal rats and single-dose one day-study and multiple-dose twenty one day- study in diabetic rats. Results: The effect on the insulin level with the treatment by formulations suggests that the mode of action is a similar to that of Glibenclamide. Oral administration of F1 and F2 for 21 days significantly reduced blood glucose level in STZ induced diabetic rats. Both the formulations exhibited antihyperglycemic effect in glucose loaded rats and STZ induced rats. The blood glucose was significantly increased. Supplementation with F1 and F2 both with (250 and 500 mg/kg) showed reduction in the blood glucose levels and improved glucose tolerance, suggesting that there was an improvement in STZ-induced deleterious effects. Conclusion: This study reveals that F1 and F2 improved STZ-induced hyperglycemia, this effect may be mediated by interacting with multiple targets operating in diabetes mellitus.
2. Roglic G, Unwin N, Bennett PH. The burden of mortality attributable to diabetes. Diabetes Care 2005; 28:2130-35.
3. Handa SS. "Future of traditional system of medicine Herbal industry". The Eastern Pharmacist, July 1998.
4. Gagetia GC, Baliga MS, Aruna R, Rajnikant GK, Jain V. Effect of Abana on eadiation -induced mortility in mice. J Ethanolpharmacol 2003; 86: 159-65.
5. Ansarullah, Jadeja R N, Thounaojam M C, Patel V, Devkar R V, Ramachandran A V. Antihyperlipidemic potential of a polyherbal preparation on Triton WR 1339(Tyloxapol) induced hyperlipidemia: A Comparison with Lovastatin. Intl J Green Pharmacy 2009; 119-24
6. OECD/OCED. OECD Guidelines for testing of chemicals. Acute oral toxicity-fixed dose procedure. 420, modified, Adopted 23rd Mar. 2006
7. Mondal S, Dash GK. Hypoglycemic activity of the bark of Spondias pinnata Linn. Kurz. Phcog Meg, 2009; 5(19):42-45.
8. Bhopale GM, More SM, Damame MM, Nanda RK. Antihyperglycemic activity of Phyllanthus reticulates leaves extract in normal and alloxan induced diabetic mice.Indian Drugs. 2007; 44(8):615-17.
9. Badole S, Patel N, Bodhankar S, Jain B, Bhardwaj S. Antihyperglycemic activity of aqueous extract of leaves of Cocculus hirsutus (L.) Diels in alloxan induced diabetic mice. Indian J Pharmocol. 2006; 38: 49-53.
10. Rameshbabu K, Vinay K, Sameeena S K, Prasad SV, Swapna S, Apparao Ch. Antihyperglycemic and antioxidant effect of Talinum portulacifolium leaf extract in streptozotocin diabetic rats: A dose dependent study. Phcog Mag, 2009; 5(19): 1-10.
11. Suresh DK, Waseem A, Asim A. Antihyperglycemic activity of Iris ensata thunb root extraxts in normal, glucose fed and streptozotocin induced diabetic rats. Adv Pharmocol toxocol 2010; 11(3):93-101.
12. Friedewald WT, Levy RI, Fredrickson DS. Estimation of low-density lipoprotein cholesterol in plasma, without use of the preparative centrifuge. Clin Chem 1972; 18:499.